Barclays Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10
BofA Securities Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $9.5
RBC Capital Maintains Teladoc Health(TDOC.US) With Buy Rating, Cuts Target Price to $10
Teladoc Health Is Maintained at In-Line by Evercore ISI Group
Teladoc Health Analyst Ratings
Evercore Maintains Teladoc Health(TDOC.US) With Hold Rating, Cuts Target Price to $9
Barclays Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10
Truist Financial Maintains Teladoc Health(TDOC.US) With Hold Rating
BofA Securities Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $9.5
Teladoc Health Is Maintained at Hold by Jefferies
Teladoc Health Analyst Ratings
Jefferies Maintains Teladoc Health(TDOC.US) With Hold Rating, Cuts Target Price to $10
D.A. Davidson Maintains Teladoc Health(TDOC.US) With Hold Rating
BofA Securities Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $9.5
Teladoc Health Price Target Cut to $9.00/Share From $16.00 by JP Morgan
Teladoc Health Analyst Ratings
JP Morgan Maintains Neutral on Teladoc Health, Lowers Price Target to $9
J.P. Morgan Maintains Teladoc Health(TDOC.US) With Hold Rating, Cuts Target Price to $9
Teladoc Health Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Teladoc Health, Maintains $10 Price Target